XML 47 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details) (USD $)
0 Months Ended 9 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended 0 Months Ended 3 Months Ended 9 Months Ended
Feb. 08, 2012
Sep. 26, 2014
Sep. 27, 2013
Sep. 26, 2014
Technolab [Member]
Sep. 26, 2014
Restricted Stock Units (RSUs) [Member]
Feb. 08, 2012
Performance Shares [Member]
Sep. 26, 2014
Performance Shares [Member]
Feb. 08, 2012
Performance Shares [Member]
Chief Executive Officer [Member]
Feb. 08, 2012
Performance Shares [Member]
Chief Operating Officer [Member]
Sep. 26, 2014
Stock Appreciation Rights (SARs) [Member]
Sep. 27, 2013
Stock Appreciation Rights (SARs) [Member]
Sep. 26, 2014
Stock Appreciation Rights (SARs) [Member]
Sep. 27, 2013
Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Growth of Pro-forma EPS Percentage 50.00%                        
Growth of Pro-forma EBITDA percentage 50.00%                        
Restricted stock units granted         839,031                
Weighted average grant-date fair value         $ 5.91 $ 0.96              
Weighted average period, Restricted stock units         2 years 1 month 6 days                
Weighted average period, Common stock   3 years 3 months 18 days                      
Performance based stock option grant, Exercise price $ 4.00                        
Trailing period             12 months            
Performance based stock option grant           2,916,563   1,912,500 1,004,063        
Total share based compensation   $ 4,185,000 $ 4,702,000             $ 100,000 $ 400,000 $ 100,000 $ 400,000
Restricted stock units outstanding         2,293,058                
Nonvested weighted average grant-date fair value         $ 5.33                
Compensation expenses related to unvested restricted stock unit based awards       164,474 7,300,000                
Shares subject to vesting requirements   264,474   6.04                  
Nonvested weighted average grant-date fair value, Common stock   $ 7.54                      
Compensation expense related to common stock subject to vesting requirements   $ 1,000,000                      
Term of the award             6 years